Prevalence of hepatitis delta virus among chronic hbvcarriers at AOU Federico II. (March 2023)
- Record Type:
- Journal Article
- Title:
- Prevalence of hepatitis delta virus among chronic hbvcarriers at AOU Federico II. (March 2023)
- Main Title:
- Prevalence of hepatitis delta virus among chronic hbvcarriers at AOU Federico II
- Authors:
- Cossiga, V.
De Conte, A.
Brusa, S.
Molinari, E.A.
Pignata, L.
Ranieri, L.
Zacchia, E.
Mazzitelli, F.
Guarino, M.
Portella, G.
Morisco, F. - Abstract:
- Abstract : Background/Aim: In Italy, the prevalence of HDV infection in HBsAg carriers is about 9.9% (6.4% in Italian natives and 26.4% in immigrants). However, the actual prevalence is probably underestimated because the anti-HDV test is not performed routinely in all HBsAg carriers. The HDV causes a rapidly progressive liver disease and as new antiviral therapies are coming, it is fundamental to known the exact HDV prevalence. The aim of this study was to assess the real HDV prevalence in the AOU Federico II. Methods: From April 2021 to July 2022, reflex test for the detection of total HDV antibodies was performed in all HBsAg positive subjects observed at AOU Federico II. Demographic, clinical and laboratory data were collected. Liver fibrosis was evaluated with FIB-4. Sera were evaluated with ADVIA Centaur HBsAgII Qualitative, Liaison Murex HBsAg Quantitative and Liaison Murex Total Anti-HDV Qualitative. Results: Of 365 HBsAg carriers, 46 (12.6%) resulted positive for total anti-HDV. The majority of them (89.2%) were Italian natives and only 5 (10.8%) of them were immigrants. Twenty-one (45.6%) were males with a median age of 62.2 years. Thirty-five (76%) patients were already aware of HBV/HDV coinfection. HDV-RNA was performed in 18 (39.1%) subjects and resulted detectable in 15 (83.3%) of them, with a median HDV-RNA level of 84.300 [25 th – 75 th percentiles: 1.685-547.796] IU/ml. Twenty (43.5%) anti-HDV positive subjects had advanced liver fibrosis. Conclusions: OurAbstract : Background/Aim: In Italy, the prevalence of HDV infection in HBsAg carriers is about 9.9% (6.4% in Italian natives and 26.4% in immigrants). However, the actual prevalence is probably underestimated because the anti-HDV test is not performed routinely in all HBsAg carriers. The HDV causes a rapidly progressive liver disease and as new antiviral therapies are coming, it is fundamental to known the exact HDV prevalence. The aim of this study was to assess the real HDV prevalence in the AOU Federico II. Methods: From April 2021 to July 2022, reflex test for the detection of total HDV antibodies was performed in all HBsAg positive subjects observed at AOU Federico II. Demographic, clinical and laboratory data were collected. Liver fibrosis was evaluated with FIB-4. Sera were evaluated with ADVIA Centaur HBsAgII Qualitative, Liaison Murex HBsAg Quantitative and Liaison Murex Total Anti-HDV Qualitative. Results: Of 365 HBsAg carriers, 46 (12.6%) resulted positive for total anti-HDV. The majority of them (89.2%) were Italian natives and only 5 (10.8%) of them were immigrants. Twenty-one (45.6%) were males with a median age of 62.2 years. Thirty-five (76%) patients were already aware of HBV/HDV coinfection. HDV-RNA was performed in 18 (39.1%) subjects and resulted detectable in 15 (83.3%) of them, with a median HDV-RNA level of 84.300 [25 th – 75 th percentiles: 1.685-547.796] IU/ml. Twenty (43.5%) anti-HDV positive subjects had advanced liver fibrosis. Conclusions: Our data showed that the HDV prevalence is higher than expected, demonstrating that the reflex test in HBsAg carriers could be a useful approach to identify the real prevalence of HDV infection. Moreover, the HDV-RNA is performed only in the minority of the anti-HDV positive subjects. In this setting, due to the forthcoming approval of specific anti-HDV drugs, a reflex test for HDV-RNA should be implemented to identify viremic patients needing antiviral treatment. … (more)
- Is Part Of:
- Digestive and liver disease. Volume 55(2023)Supplement 1
- Journal:
- Digestive and liver disease
- Issue:
- Volume 55(2023)Supplement 1
- Issue Display:
- Volume 55, Issue 1 (2023)
- Year:
- 2023
- Volume:
- 55
- Issue:
- 1
- Issue Sort Value:
- 2023-0055-0001-0000
- Page Start:
- S19
- Page End:
- S20
- Publication Date:
- 2023-03
- Subjects:
- Digestive organs -- Diseases -- Periodicals
Liver -- Diseases -- Periodicals
616.33005 - Journal URLs:
- http://www.sciencedirect.com/science/journal/15908658 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.dld.2023.01.034 ↗
- Languages:
- English
- ISSNs:
- 1590-8658
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3588.345600
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 26158.xml